Aethlon Medical, Inc. (AEMD) vs Universe Pharmaceuticals Inc. (UPC)
A side-by-side comparison of Aethlon Medical, Inc. and Universe Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AEMD
Aethlon Medical, Inc.
$6.09HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
UPC
Universe Pharmaceuticals Inc.
$4.21HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AEMD vs UPC
growth of $100 · dividends reinvested · last 6yAEMD -99.9% (-70.1%/yr)UPC -100.0% (-74.8%/yr)AEMD compounded faster over this window
AEMD UPC
AEMD vs UPC: by the numbers
- •AEMD is the larger company ($3M vs $3M market cap).
- •Both run net losses; AEMD's is the smaller (0.00% vs -20.56% net margin).
Metrics side by side
Valuation
| Metric | AEMD | UPC |
|---|---|---|
| P/B ratio | 0.62 | 0.05 |
Profitability
| Metric | AEMD | UPC |
|---|---|---|
| Gross margin | 0.00% | 35.28% |
| Operating margin | 0.00% | -16.33% |
| Net margin | 0.00% | -20.56% |
| ROE | -133.43% | -6.54% |
| ROIC | -133.29% | -4.46% |
Growth (annualized)
| Metric | AEMD | UPC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -10.27% |
| Total return CAGR (5Y) | -78.27% | -78.19% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.